Harrow, Inc. Capital Leases, Future Minimum Payments, Interest Included in Payments
Harrow, Inc. (HROW) had Capital Leases, Future Minimum Payments, Interest Included in Payments of $15.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments · last filed 2019-03-12
- 2018-12-31: Capital Leases, Future Minimum Payments, Interest Included in Payments $15.00K.
- 2018-09-30: Capital Leases, Future Minimum Payments, Interest Included in Payments $29.00K.
- 2018-06-30: Capital Leases, Future Minimum Payments, Interest Included in Payments $48.00K.
- 2018-03-31: Capital Leases, Future Minimum Payments, Interest Included in Payments $70.00K.
| Period end | Capital Leases, Future Minimum Payments, Interest Included in Payments |
|---|---|
| 2018-12-31 | $15.00K 10-K · filed 2019-03-12 |
| 2018-09-30 | $29.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $48.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | $70.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $96.00K 10-K · filed 2018-03-08 |
| 2017-09-30 | $128.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $163.00K 10-Q · filed 2017-08-10 |
| 2017-03-31 | $202.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $244.00K 10-K · filed 2017-03-21 |
| 2016-09-30 | -$590.00K 10-Q · filed 2016-11-14 |
| 2015-12-31 | $1.00K 10-K · filed 2016-03-23 |
| 2015-09-30 | $1.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $3.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $2.00K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $1.72K 10-K · filed 2015-03-12 |
| 2014-09-30 | $2.22K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $927.00 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |